1
King Terry D, Mills Noel L: Shunt defect closure system. Alton Ochsner Medical Foundation, Pugh & Laiche, April 1, 1975: US3874388 (1208 worldwide citation)

A method and apparatus for closing off a septal defect or shunt in the intravascular system or the great vessels including a pair of opposed, umbrella-like elements locked together in face-to-face relationship on opposite sides of the septal defect, thereby closing it. The dual umbrella-like closure ...


2
King Terry D, Mills Noel L: Systeme dobturation dintercommunications vasculaires, Shunt defect closure system. Alton Ochsner Medical Foundation, January 2, 1979: CA1045304 (3 worldwide citation)

- S P E C I F I C A T I O N - SHUNT DEFECT CLOSURE SYSTEM Abstract of the Disclosure A method and apparatus for closing off a septaldefect or shunt in the intravascular system or the greatvessels including a pair of opposed, umbrella-like elementslocked together in face-to-face relationship on oppos ...


3
Shunt defect closure system. Ochsner Med Found Alton, October 22, 1976: FR2305165-A1 (2 worldwide citation)

A method and apparatus for closing off a septal defect or shunt in the intravascular system or the great vessels including a pair of opposed, umbrella-like elements locked together in face-to-face relationship on opposite sides of the septal defect, thereby closing it. The dual umbrella-like closure ...


4
Alternative Use for Hydrogel intrasaccular Occlusion Device with a Spring for Structural Support. July 12, 2018: US20180193023-A1

The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be ...


5
Alternative us of hydrogel intrasaccular occlusion device with center supporting bar for structrual support. July 12, 2018: US20180193024-A1

The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be ...


6
Alternative use for hydrogel intrasaccular occlusion device with an umbrella member for structural support. July 12, 2018: US20180193025-A1

The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be ...


7
Alternative Use for Hydrogel Intrasaccular Occlusion Device with Radial Bars for Structural Support. July 26, 2018: US20180206848-A1

The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be ...


8
Alternative use for hydrogel intrasaccular occlusion device with vertically oriented reinforcement members for structural support. August 2, 2018: US20180214158-A1

The present disclosure relates to the field of endovascular treatment. More particularly, the present invention uses a modified hydrogel intrasaccular occlusion device designed to implement an endovascular treatment to ameliorating or eliminating aneurysm recurrence, which hydrogel may optionally be ...